688505 复旦张江
已收盘 12-31 15:00:00
资讯
新帖
简况
每周股票复盘：复旦张江（688505）肺癌术中显影获临床受理
证券之星 · 2025-12-28
每周股票复盘：复旦张江（688505）肺癌术中显影获临床受理
复旦张江最新公告：注射用FZ-P001钠用于已知或疑似肺癌患者术中恶性病变可视化的II期临床试验申请获得受理
证券之星 · 2025-12-25
复旦张江最新公告：注射用FZ-P001钠用于已知或疑似肺癌患者术中恶性病变可视化的II期临床试验申请获得受理
复旦张江（688505）披露拟变更部分募投项目及取消监事会，11月26日股价下跌0.46%
证券之星 · 2025-11-26
复旦张江（688505）披露拟变更部分募投项目及取消监事会，11月26日股价下跌0.46%
复旦张江(01349)：曲亚楠获选为职工董事
智通财经 · 2025-11-26
复旦张江(01349)：曲亚楠获选为职工董事
复旦张江：2025年9月30日，公司股东总数21141户
证券日报 · 2025-11-25
复旦张江：2025年9月30日，公司股东总数21141户
复旦张江(01349)股东杨宗孟拟减持公司股份不超过约1036.57万股
智通财经 · 2025-11-04
复旦张江(01349)股东杨宗孟拟减持公司股份不超过约1036.57万股
每周股票复盘：复旦张江（688505）拟取消监事会并变更募投项目
证券之星 · 2025-11-02
每周股票复盘：复旦张江（688505）拟取消监事会并变更募投项目
复旦张江（688505）披露变更部分募集资金投资项目公告，10月31日股价上涨1.53%
证券之星 · 2025-10-31
复旦张江（688505）披露变更部分募集资金投资项目公告，10月31日股价上涨1.53%
复旦张江（688505）披露拟取消监事会并变更部分募投项目公告，10月30日股价下跌2.13%
证券之星 · 2025-10-30
复旦张江（688505）披露拟取消监事会并变更部分募投项目公告，10月30日股价下跌2.13%
复旦张江(01349)发布前三季度业绩 归母净亏损1593.65万元 同比盈转亏
智通财经 · 2025-10-30
复旦张江(01349)发布前三季度业绩 归母净亏损1593.65万元 同比盈转亏
每周股票复盘：复旦张江（688505）将召开Q3业绩说明会
证券之星 · 2025-10-26
每周股票复盘：复旦张江（688505）将召开Q3业绩说明会
复旦张江（688505）披露召开2025年第三季度业绩说明会，10月23日股价下跌0.22%
证券之星 · 2025-10-23
复旦张江（688505）披露召开2025年第三季度业绩说明会，10月23日股价下跌0.22%
复旦张江 -集团同意认购1亿人民币结构性存款产品
美股速递 · 2025-10-15
复旦张江 -集团同意认购1亿人民币结构性存款产品
复旦张江(01349)认购总金额为1亿元的招商银行结构性存款产品
智通财经 · 2025-10-15
复旦张江(01349)认购总金额为1亿元的招商银行结构性存款产品
复旦张江拟认购总额1.7亿元结构性存款产品
美股速递 · 2025-10-14
复旦张江拟认购总额1.7亿元结构性存款产品
复旦张江(01349)认购1.7亿元结构性存款产品
智通财经 · 2025-10-14
复旦张江(01349)认购1.7亿元结构性存款产品
复旦张江(01349)：奥贝胆酸片用于治疗原发性胆汁性胆管炎药物上市申请未获批准
智通财经 · 2025-10-13
复旦张江(01349)：奥贝胆酸片用于治疗原发性胆汁性胆管炎药物上市申请未获批准
复旦张江奥贝胆酸片新药申请未获批准
美股速递 · 2025-10-13
复旦张江奥贝胆酸片新药申请未获批准
复旦张江认购2.1亿元的结构性存款产品
新浪港股 · 2025-10-13
复旦张江认购2.1亿元的结构性存款产品
复旦张江(01349)认购2.1亿元的结构性存款产品
智通财经 · 2025-10-10
复旦张江(01349)认购2.1亿元的结构性存款产品
加载更多
公司概况
公司名称：
上海复旦张江生物医药股份有限公司
所属行业：
医药制造业
上市日期：
2020-06-19
主营业务：
上海复旦张江生物医药股份有限公司的主营业务是生物医药的创新研究开发、生产制造和市场营销。公司的主要产品是皮肤科产品、抗肿瘤产品。
发行价格：
8.95
{"stockData":{"symbol":"688505","market":"SH","secType":"STK","nameCN":"复旦张江","latestPrice":8.3,"timestamp":1767164400000,"preClose":8.24,"halted":0,"volume":2089374,"delay":0,"changeRate":0.0073,"floatShares":711000000,"shares":1036999999,"eps":-0.0605,"marketStatus":"已收盘","change":0.06,"latestTime":"12-31 15:00:00","open":8.23,"high":8.32,"low":8.19,"amount":17268800,"amplitude":0.0158,"askPrice":8.31,"askSize":134,"bidPrice":8.3,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-0.0605,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767576600000},"marketStatusCode":5,"adr":0,"adjPreClose":8.24,"symbolType":"stock_kcb","openAndCloseTimeList":[[1767144600000,1767151800000],[1767157200000,1767164400000]],"highLimit":9.06,"lowLimit":7.42,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1036572100,"isCdr":false,"pbRate":3.81,"roa":"--","roe":"--","epsLYR":0.04,"committee":0,"marketValue":8604000000,"turnoverRate":0.0029,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-01-05。","afterMarket":{"amount":0,"volume":0,"close":8.3,"buyVolume":0,"sellVolume":0,"time":1767166437558,"indexStatus":"已收盘 12-31 15:30:00","preClose":8.24},"hkstockBrief":{"symbol":"01349","market":"HK","secType":"STK","nameCN":"复旦张江","latestPrice":2.82,"timestamp":1767341324827,"preClose":2.78,"halted":0,"volume":85000,"delay":0,"premium":"-69.62"},"floatMarketCap":5898000000},"requestUrl":"/m/hq/s/688505","defaultTab":"news","newsList":[{"id":"2594479032","title":"每周股票复盘：复旦张江（688505）肺癌术中显影获临床受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2594479032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594479032?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:17","pubTimestamp":1766870230,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，复旦张江报收于8.32元，较上周的8.41元下跌1.07%。本周关注点公司公告汇总：注射用FZ-P001钠用于肺癌术中显影获II期临床试验受理。目前该药物已完成卵巢癌适应症I期临床试验，新适应症II期临床试验申请已获受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688505","BK0239","01349","BK1191"],"gpt_icon":0},{"id":"2594360722","title":"复旦张江最新公告：注射用FZ-P001钠用于已知或疑似肺癌患者术中恶性病变可视化的II期临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2594360722","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594360722?lang=zh_cn&edition=full","pubTime":"2025-12-25 18:20","pubTimestamp":1766658045,"startTime":"0","endTime":"0","summary":"复旦张江(688505.SH)公告称，公司于近日收到国家药品监督管理局核准签发的《受理通知书》，注射用FZ-P001钠用于已知或疑似肺癌患者术中恶性病变可视化的II期临床试验申请获得受理。该药物为公司自主研发的化学药品1类新化合物，是一种创新型光敏剂，可靶向叶酸受体α（FRα）高表达的恶性肿瘤组织并在近红外区间荧光显影。公司计划使用该药物开发术中荧光指引技术，提高相关实体瘤手术切除效果。由于医药产品研发周期长、审批环节多，存在不确定性，敬请投资者谨慎决策，注意投资风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500027941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","688505","BK0239","01349"],"gpt_icon":0},{"id":"2586263141","title":"复旦张江（688505）披露拟变更部分募投项目及取消监事会，11月26日股价下跌0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586263141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586263141?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:43","pubTimestamp":1764168201,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，复旦张江报收于8.57元，较前一交易日下跌0.46%，最新总市值为88.83亿元。根据公司近日发布的公告，复旦张江于2025年11月26日召开2025年第一次临时股东大会，会议审议通过了关于变更部分募集资金投资项目的议案、关于修订《公司章程》及取消监事会的议案、关于修订《股东大会议事规则》的议案以及关于修订《董事会议事规则》的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600039278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","688505","01349"],"gpt_icon":0},{"id":"2586251756","title":"复旦张江(01349)：曲亚楠获选为职工董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2586251756","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586251756?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:09","pubTimestamp":1764158970,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江(01349)发布公告，公司于2025年11月26日召开第三届职工代表大会第三次会议，审议并通过了《第八届董事会职工董事候选人及委任》的议案。经会议选举，曲亚楠女士获选为公司第八届董事会职工董事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01349","BK0239","688505","BK1191"],"gpt_icon":0},{"id":"2586476302","title":"复旦张江：2025年9月30日，公司股东总数21141户","url":"https://stock-news.laohu8.com/highlight/detail?id=2586476302","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586476302?lang=zh_cn&edition=full","pubTime":"2025-11-25 21:38","pubTimestamp":1764077906,"startTime":"0","endTime":"0","summary":"证券日报网讯复旦张江11月25日在互动平台回答投资者提问时表示，截至2025年9月30日，公司股东总数21，141户，其中A股21，005户，H股136户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511253574466232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01349","BK1191","BK0239","688505"],"gpt_icon":0},{"id":"2580878109","title":"复旦张江(01349)股东杨宗孟拟减持公司股份不超过约1036.57万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2580878109","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580878109?lang=zh_cn&edition=full","pubTime":"2025-11-04 18:23","pubTimestamp":1762251811,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江(01349)公布，公司于近日收到股东杨宗孟先生发来的《关于减持复旦张江股份计划的告知函》，因自身资金需求，杨宗孟先生计划自本公告披露之日起 15 个交易日后的 3 个月内通过集中竞价的方式减持公司股份不超过 10,365,721 股，拟减持比例不超过公司总股本的 1.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688505","BK0239","BK1191","01349"],"gpt_icon":0},{"id":"2580724224","title":"每周股票复盘：复旦张江（688505）拟取消监事会并变更募投项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2580724224","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580724224?lang=zh_cn&edition=full","pubTime":"2025-11-02 06:58","pubTimestamp":1762037892,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，复旦张江报收于9.31元，较上周的9.05元上涨2.87%。来自公司公告汇总：复旦张江拟取消监事会，由董事会审核委员会承接其职权。股本股东变化股东户数变动截至2025年9月30日，复旦张江股东户数为2.1万户，较6月30日增加1268户，增幅6.42%。公司公告汇总复旦张江第八届监事会第十一次会议决议公告2025年10月30日，复旦张江第八届监事会第十一次会议以现场方式召开，应到监事3人，实到3人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","688505","BK0239","01349"],"gpt_icon":0},{"id":"2579932074","title":"复旦张江（688505）披露变更部分募集资金投资项目公告，10月31日股价上涨1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579932074","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579932074?lang=zh_cn&edition=full","pubTime":"2025-10-31 22:27","pubTimestamp":1761920842,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，复旦张江报收于9.31元，较前一交易日上涨1.53%，最新总市值为96.5亿元。该股当日开盘9.11元，最高9.37元，最低9.11元，成交额达7016.16万元，换手率为1.06%。公司近日发布公告称，拟将原募投项目“海姆泊芬美国注册项目”变更为“光动力药物创新研发持续发展项目”，变更募集资金金额为18,154.61万元，新项目建设周期至2027年12月31日。本次变更有利于提升资金使用效率，聚焦光动力技术平台研发。该事项尚需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100049739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688505","BK1191","01349","BK0239"],"gpt_icon":0},{"id":"2579125966","title":"复旦张江（688505）披露拟取消监事会并变更部分募投项目公告，10月30日股价下跌2.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579125966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579125966?lang=zh_cn&edition=full","pubTime":"2025-10-30 22:23","pubTimestamp":1761834197,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘，复旦张江报收于9.17元，较前一交易日下跌2.13%，最新总市值为95.05亿元。该股当日开盘9.4元，最高9.4元，最低9.15元，成交额达5895.82万元，换手率为0.9%。根据公告，公司拟取消监事会，原监事会职权将由董事会审核委员会承接，相关内部制度也将进行相应调整。此外，会议还审议通过了《关于变更部分募集资金投资项目的议案》及《关于公司2025年第三季度报告的议案》，所有议案均获全票通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000045274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","01349","BK1191","688505"],"gpt_icon":0},{"id":"2579711478","title":"复旦张江(01349)发布前三季度业绩 归母净亏损1593.65万元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2579711478","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579711478?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:43","pubTimestamp":1761821019,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江(01349)发布截至2025年9月30日止9个月业绩，该集团期内取得营业收入5.51亿元人民币，同比增加0.41%;归属于上市公司股东的净亏损1593.65万元，同比盈转亏;基本每股亏损0.02元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","688505","01349"],"gpt_icon":0},{"id":"2578507667","title":"每周股票复盘：复旦张江（688505）将召开Q3业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2578507667","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578507667?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:42","pubTimestamp":1761421333,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，复旦张江报收于9.05元，较上周的8.94元上涨1.23%。本周，复旦张江10月22日盘中最高价报9.2元。本周关注点公司公告汇总：复旦张江将于2025年10月31日召开第三季度业绩说明会。公司公告汇总复旦张江关于召开2025年第三季度业绩说明会的公告上海复旦张江生物医药股份有限公司将于2025年10月31日（周五）上午11:00-12:00通过上证路演中心举行2025年第三季度业绩说明会，就公司经营成果及财务状况与投资者进行网络互动交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688505","BK1191","01349"],"gpt_icon":0},{"id":"2577585635","title":"复旦张江（688505）披露召开2025年第三季度业绩说明会，10月23日股价下跌0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577585635","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577585635?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:37","pubTimestamp":1761230230,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，复旦张江报收于9.06元，较前一交易日下跌0.22%，最新总市值为93.91亿元。近日，复旦张江发布关于召开2025年第三季度业绩说明会的公告。公告称，上海复旦张江生物医药股份有限公司将于2025年10月31日（周五）上午11:00-12:00通过上证路演中心举行2025年第三季度业绩说明会，就公司经营成果及财务状况与投资者进行网络互动交流。公司拟于同日披露2025年第三季度报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300037937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688505","01349","BK1191"],"gpt_icon":0},{"id":"1195424612","title":"复旦张江 -集团同意认购1亿人民币结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1195424612","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195424612?lang=zh_cn&edition=full","pubTime":"2025-10-15 17:25","pubTimestamp":1760520310,"startTime":"0","endTime":"0","summary":"复旦张江 -集团同意认购1亿人民币结构性存款产品","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2575078292","title":"复旦张江(01349)认购总金额为1亿元的招商银行结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2575078292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575078292?lang=zh_cn&edition=full","pubTime":"2025-10-15 17:23","pubTimestamp":1760520238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江(01349)发布公告，近日，公司与招商银行订立招商银行结构性存款产品协议I，公司的全资附属公司泰州复旦张江与招商银行订立招商银行结构性存款产品协议II，据此，集团同意以日常营运产生的自有闲置资金向招商银行认购总金额为人民币1.00亿元的结构性存款产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1720050803.USD","LU0502904849.HKD","03968","LU0488056044.USD","LU0417516738.SGD","BK0188","BK0070","LU2289578879.USD","LU0327786744.USD","LU0588546209.SGD","LU0708995153.HKD","LU0823426308.USD","IE00B3M56506.USD","03143","BK0015","LU1255011170.USD","LU2476274720.SGD","LU2495084118.USD","LU1655091616.SGD","688505","LU0210526637.USD","LU1282649141.HKD","LU0417516902.SGD","LU0314109678.HKD","LU0029874905.USD","LU1064131003.USD","600036","LU0918141705.HKD","LU1366334651.USD","LU0634319403.HKD","LU1808992512.USD","LU2226246903.HKD","LU0072913022.USD","LU0173614495.USD","SG9999004220.SGD","LU0880133367.SGD","BK0187","LU1794554557.SGD","LU2148510915.USD","LU0067412154.USD","01349","IE0008368742.USD","LU1675838814.USD","LU0359201612.USD","LU0348827113.USD","SG9999002463.SGD","LU0890818403.SGD","LU0326950275.SGD","LU0862451753.SGD"],"gpt_icon":0},{"id":"1145742209","title":"复旦张江拟认购总额1.7亿元结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1145742209","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145742209?lang=zh_cn&edition=full","pubTime":"2025-10-14 16:56","pubTimestamp":1760432171,"startTime":"0","endTime":"0","summary":"复旦张江计划认购总金额为1.7亿元人民币的结构性存款产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2575953267","title":"复旦张江(01349)认购1.7亿元结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2575953267","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575953267?lang=zh_cn&edition=full","pubTime":"2025-10-14 16:56","pubTimestamp":1760432161,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江(01349)发布公告，近日，公司与中国银行订立中国银行结构性存款产品协议I及中国银行结构性存款产品协议II，同意以A股公开发行所得暂时闲置募集资金向中国银行认购总金额为人民币1.70亿元的结构性存款产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01349","BK1191","688505","BK0239"],"gpt_icon":0},{"id":"2575472321","title":"复旦张江(01349)：奥贝胆酸片用于治疗原发性胆汁性胆管炎药物上市申请未获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2575472321","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575472321?lang=zh_cn&edition=full","pubTime":"2025-10-13 18:05","pubTimestamp":1760349950,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江(01349)发布公告，公司的附属公司泰州复旦张江药业有限公司收到国家药品监督管理局签发的《药品上市申请不予批准通知书》，奥贝胆酸片(规格：5mg、10mg)用于治疗原发性胆汁性胆管炎(PBC)的药物上市申请未获批准。本次不予批准的原因是：该药物为境外附条件批准上市境内未上市药品的仿制药，参比制剂原研在国外未获得常规批准，同时鉴于目前原研上市后研究结论明确缺乏确证的获益、且存在严重风险而无法支持奥贝胆酸用于境外已批准适应症的获益大于风险，认为现有资料无法充分支持该药物按照 3 类仿制药常规批准的技术要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","01349","BK1191","688505"],"gpt_icon":0},{"id":"1110974233","title":"复旦张江奥贝胆酸片新药申请未获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1110974233","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110974233?lang=zh_cn&edition=full","pubTime":"2025-10-13 18:04","pubTimestamp":1760349855,"startTime":"0","endTime":"0","summary":"复旦张江奥贝胆酸片新药申请未获批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2575788441","title":"复旦张江认购2.1亿元的结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2575788441","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575788441?lang=zh_cn&edition=full","pubTime":"2025-10-13 08:52","pubTimestamp":1760316720,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 复旦张江（01349）发布公告，近日，本公司与浦发银行订立浦发银行结构性存款产品协议，同意以日常营运产生的自有闲置资金向浦发银行认购总金额为人民币2.10亿元的结构性存款产品。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-10-13/doc-infttaaq8443683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01349","688505","BK1191","BK0239"],"gpt_icon":0},{"id":"2574853176","title":"复旦张江(01349)认购2.1亿元的结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2574853176","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574853176?lang=zh_cn&edition=full","pubTime":"2025-10-10 20:19","pubTimestamp":1760098763,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江(01349)发布公告，近日，本公司与浦发银行订立浦发银行结构性存款产品协议，同意以日常营运产生的自有闲置资金向浦发银行认购总金额为人民币2.10亿元的结构性存款产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688505","BK1191","01349","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767348576141,"stockEarnings":[{"period":"1week","weight":0.0024},{"period":"1month","weight":-0.0338},{"period":"3month","weight":-0.0899},{"period":"6month","weight":-0.0802},{"period":"1year","weight":0.0853},{"period":"ytd","weight":0.0853}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.014},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.143},{"period":"1year","weight":0.1841},{"period":"ytd","weight":0.1841}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海复旦张江生物医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21005人(较上一季度增加6.42%)","perCapita":"33828股","listingDate":"2020-06-19","address":"上海市浦东新区张江高科技园区蔡伦路308号","registeredCapital":"10365万元","survey":" 上海复旦张江生物医药股份有限公司的主营业务是生物医药的创新研究开发、生产制造和市场营销。公司的主要产品是皮肤科产品、抗肿瘤产品。","listedPrice":8.95},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复旦张江,688505,复旦张江股票,复旦张江股票老虎,复旦张江股票老虎国际,复旦张江行情,复旦张江股票行情,复旦张江股价,复旦张江股市,复旦张江股票价格,复旦张江股票交易,复旦张江股票购买,复旦张江股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}